Your browser doesn't support javascript.
loading
Clinical and multi-omics cross-phenotyping of patients with autoimmune and autoinflammatory diseases: the observational TRANSIMMUNOM protocol.
Lorenzon, Roberta; Mariotti-Ferrandiz, Encarnita; Aheng, Caroline; Ribet, Claire; Toumi, Ferial; Pitoiset, Fabien; Chaara, Wahiba; Derian, Nicolas; Johanet, Catherine; Drakos, Iannis; Harris, Sophie; Amselem, Serge; Berenbaum, Francis; Benveniste, Olivier; Bodaghi, Bahram; Cacoub, Patrice; Grateau, Gilles; Amouyal, Chloe; Hartemann, Agnes; Saadoun, David; Sellam, Jeremie; Seksik, Philippe; Sokol, Harry; Salem, Joe-Elie; Vicaut, Eric; Six, Adrien; Rosenzwajg, Michelle; Bernard, Claude; Klatzmann, David.
Afiliación
  • Lorenzon R; Immunology, Immunopathology, Immunotherapy (i3), Sorbonne Université, INSERM, Paris, France.
  • Mariotti-Ferrandiz E; Biotherapy (CIC-BTi) and Inflammation, Immunopathology, Biotherapy Department (i2B), Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Aheng C; Immunology, Immunopathology, Immunotherapy (i3), Sorbonne Université, INSERM, Paris, France.
  • Ribet C; Immunology, Immunopathology, Immunotherapy (i3), Sorbonne Université, INSERM, Paris, France.
  • Toumi F; Biotherapy (CIC-BTi) and Inflammation, Immunopathology, Biotherapy Department (i2B), Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Pitoiset F; Immunology, Immunopathology, Immunotherapy (i3), Sorbonne Université, INSERM, Paris, France.
  • Chaara W; Biotherapy (CIC-BTi) and Inflammation, Immunopathology, Biotherapy Department (i2B), Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Derian N; Immunology, Immunopathology, Immunotherapy (i3), Sorbonne Université, INSERM, Paris, France.
  • Johanet C; Immunology, Immunopathology, Immunotherapy (i3), Sorbonne Université, INSERM, Paris, France.
  • Drakos I; Biotherapy (CIC-BTi) and Inflammation, Immunopathology, Biotherapy Department (i2B), Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Harris S; Immunology, Immunopathology, Immunotherapy (i3), Sorbonne Université, INSERM, Paris, France.
  • Amselem S; Biotherapy (CIC-BTi) and Inflammation, Immunopathology, Biotherapy Department (i2B), Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Berenbaum F; Immunology, Immunopathology, Immunotherapy (i3), Sorbonne Université, INSERM, Paris, France.
  • Benveniste O; Biotherapy (CIC-BTi) and Inflammation, Immunopathology, Biotherapy Department (i2B), Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Bodaghi B; Immunology Department, Saint-Antoine Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Cacoub P; UFR 967, Sorbonne Université, Paris, France.
  • Grateau G; Immunology, Immunopathology, Immunotherapy (i3), Sorbonne Université, INSERM, Paris, France.
  • Amouyal C; Immunology, Immunopathology, Immunotherapy (i3), Sorbonne Université, INSERM, Paris, France.
  • Hartemann A; Laboratoire de génétique, UMR S933, Sorbonne Université, INSERM, Paris, France.
  • Saadoun D; Rheumatology Department, Saint-Antoine Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Sellam J; UMR S938, Sorbonne Université, INSERM, Paris, France.
  • Seksik P; Internal Medicine and Clinical Immunology Department, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Sokol H; UMR 974, Sorbonne Université, Paris, France.
  • Salem JE; Département Hospitalo-Universitaire Vision and Handicaps 'ViewMaintain', Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris, Paris, Île-de-France, France.
  • Vicaut E; Immunology, Immunopathology, Immunotherapy (i3), Sorbonne Université, INSERM, Paris, France.
  • Six A; Internal Medicine and Clinical Immunology Department, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Rosenzwajg M; Internal Medicine Department, Tenon Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Bernard C; UMR S933, Sorbonne Université, INSERM, Paris, France.
  • Klatzmann D; Diabetology Department, Institute of Cardiometabolism and Nutrition (ICAN), Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris, Paris, Île-de-France, France.
BMJ Open ; 8(8): e021037, 2018 08 30.
Article en En | MEDLINE | ID: mdl-30166293
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Autoinmunes / Inflamación Tipo de estudio: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies Aspecto: Ethics Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: BMJ Open Año: 2018 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Autoinmunes / Inflamación Tipo de estudio: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies Aspecto: Ethics Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: BMJ Open Año: 2018 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Reino Unido